Biopsy pathology predicts patients with ulcerative colitis subsequently requiring surgery

Scandinavian Journal of Gastroenterology

Volumn 37, Issue 2, 2002, Pages 200-205

  Tanaka, Masanori ^a   Saito, Hiroshi ^a   Kusumi, Tomomi ^a   Shimoyama, Tadashi ^a   Fukuda, Shinsaku ^a   Morita, Takayuki ^a   Sugita, Akira ^a,b   Hara, Masamichi ^a,b   Kudo, Hajime ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

Biopsy; Endoscopy; Histological criteria; Surgery; Ulcerative colitis

Indexed keywords

ABSCESS; ADULT; AGE; ARTICLE; CELL INFILTRATION; COLON BIOPSY; COLON MUCOSA; COLON RESECTION; COLON ULCER; ENDOSCOPY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TREATMENT INDICATION; ULCERATIVE COLITIS;

ADULT; BIOPSY; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; COLON; FEMALE; HUMANS; LOGISTIC MODELS; MALE; PREDICTIVE VALUE OF TESTS; RECTUM; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 0036157908     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655202753416885     Document Type: Article

References (29)

1. Course of ulcerative colitis: Analysis of changes in disease activity over years
2. Ulcerative colitis in Greece: Clinicoepidemiological data, course, and prognostic factors in 413 consecutive patients
3. Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients
4. Predictors and the rate of medical treatment failure in ulcerative colitis
5. Further experience in the treatment of severe attacks of ulcerative colitis
6. Predicting outcome in severe ulcerative colitis
7. Ileostomy and excisional surgery for chronic inflammatory disease of the colon: A survey of one hospital region
8. Ileal pouch-anal anastomosis: Current status and controversies
9. Ileal pouch-anal anastomosis for chronic ulcerative colitis: Long-term results
10. Ileoanal reservoir for ulcerative colitis and familial polyposis
11. Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis
12. Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes
13. Steroid complications and surgery in intractable ulcerative colitis
14. Crohn's disease-associated genetic marker is seen in medically unresponsive ulcerative colitis patients and may be associated with pouch-specific complications
15. Relationship between glucocorticoid receptor and response to glucocorticoid therapy in ulcerative colitis
16. Atypical rectosigmoid histology in children with newly diagnosed ulcerative colitis
17. In situ comparison of phenotypical and functional activity of infiltrating cells in ulcerative colitis mucosa
18. Eosinophils in the rectal mucosa. A simple method of predicting the outcome of ulcerative proctocolitis?
19. Activated eosinophils in chronic inflammatory bowel disease
20. Tissue eosinophils in ulcerative colitis
21. Significance of eosinophil and mast cell counts in rectal mucosa in ulcerative colitis. A prospective controlled study
22. The content of eosinophil granulocytes in the colonic mucosa in ulcerative colitis
23. Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis
24. Simple mucosal biopsy criteria differentiating among Crohn's disease, ulcerative colitis, and other forms of colitis: Measurement of validity
25. Differential diagnosis of inflammatory bowel disease. A comparison of various diagnostic classifications
26. Classification of inflammatory bowel disease
27. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease
28. Patchy cecal inflammation associated with distal ulcerative colitis: A prospective endoscopic study
29. Disodium cromoglycate in the treatment of ulcerative colitis and Crohn's disease